A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes.

MLA

Magdalinou, N. K., et al. “A Panel of Nine Cerebrospinal Fluid Biomarkers May Identify Patients with Atypical Parkinsonian Syndromes.” Journal of Neurology, Neurosurgery & Psychiatry, vol. 86, no. 11, Nov. 2015, pp. 1240–47. EBSCOhost, https://doi.org/10.1136/jnnp-2014-309562.

APA

Magdalinou, N. K., Paterson, R. W., Schott, J. M., Fox, N. C., Mummery, C., Blennow, K., Bhatia, K., Morris, H. R., Giunti, P., Warner, T. T., de Silva, R., Lees, A. J., & Zetterberg, H. (2015). A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes. Journal of Neurology, Neurosurgery & Psychiatry, 86(11), 1240–1247. https://doi.org/10.1136/jnnp-2014-309562

Chicago

Magdalinou, N. K., R. W. Paterson, J. M. Schott, N. C. Fox, C. Mummery, K. Blennow, K. Bhatia, et al. 2015. “A Panel of Nine Cerebrospinal Fluid Biomarkers May Identify Patients with Atypical Parkinsonian Syndromes.” Journal of Neurology, Neurosurgery & Psychiatry 86 (11): 1240–47. doi:10.1136/jnnp-2014-309562.